Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electroacupuncture Combined with Press Needles Alleviates Simple Obesity via VEGF-C/VEGFR-3/PI3K/AKT Signaling Pathway. | Obes Facts | 2025 | 40107254 | PubTator, text mining | PubMed |
| Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling. | Invest Ophthalmol Vis Sci | 2025 | 40105819 | PubTator, text mining | PubMed |
| Conversion of T Effector Cells Into T Regulatory Cells in Type 1 Diabetes/Latent Autoimmune Diabetes of Adults by Inhibiting eIF5A and Notch Pathways. | Immunotargets Ther | 2025 | 40099149 | PubTator, text mining | PubMed |
| Case Report: A novel DLL4 variant in a neonate with Adams-Oliver syndrome. | Front Pediatr | 2025 | 40098638 | PubTator, text mining | PubMed |
| Monocyte-derived Langerhans cells express Delta-like 4 induced by peptidoglycan and interleukin-4 mediated suppression. | Front Immunol | 2025 | 40018044 | PubTator, text mining | PubMed |
| Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration. | Biomedicines | 2025 | 40002766 | PubTator, text mining | PubMed |
| Notch signaling pathway in osteogenesis, bone development, metabolism, and diseases. | FASEB J | 2025 | 39985304 | PubTator, text mining | PubMed |
| Notch2/3-DLL4 interaction in urothelial cancer cell lines supports a tumorigenic role of Notch signaling pathways in bladder carcinoma. | PLoS One | 2025 | 39951484 | PubTator, text mining | PubMed |
| A model of Notch signalling control of angiogenesis: Evidence of a role for Notch ligand heterodimerization. | PLoS Comput Biol | 2025 | 39932958 | PubTator, text mining | PubMed |
| A feedback amplifier circuit with Notch and E2A orchestrates T-cell fate and suppresses the innate lymphoid cell lineages during thymic ontogeny. | Genes Dev | 2025 | 39904558 | PubTator, text mining | PubMed |
| Hydroxytyrosol protects isoproterenol-induced myocardial infarction through activating notch signaling. | Iran J Basic Med Sci | 2025 | 39850112 | PubTator, text mining | PubMed |
| Bone-derived nanoparticles (BNPs) enhance osteogenic differentiation via Notch signaling. | Nanoscale Adv | 2025 | 39823045 | PubTator, text mining | PubMed |
| Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction. | Cell Death Dis | 2025 | 39753531 | PubTator, text mining | PubMed |
| Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer. | Int J Pharm | 2025 | 39746584 | PubTator, text mining | PubMed |
| Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs. | Immunity | 2025 | 39731910 | PubTator, text mining | PubMed |
| Multiscale simulations reveal architecture of NOTCH protein and ligand specific features. | Biophys J | 2025 | 39674890 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps activate Notch-γ-secretase signaling in hidradenitis suppurativa. | J Allergy Clin Immunol | 2025 | 39265876 | PubTator, text mining | PubMed |
| Mll4 in skeletal muscle fibers maintains muscle stem cells. | Skelet Muscle | 2024 | 39710699 | PubTator, text mining | PubMed |
| Toll-like receptors as a missing link in Notch signaling cascade during neurodevelopment. | Front Mol Neurosci | 2024 | 39664114 | PubTator, text mining | PubMed |
| Chemical transdifferentiation of somatic cells to neural cells: a systematic review. | Einstein (Sao Paulo) | 2024 | 39661857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=8